TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PAHC

Phibro Animal Health Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

37.20$ +3.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Phibro Animal Health Corporation (PAHC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 397 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PAHC
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
231 250 263 273 260 309 348 379 364 374 384 397 1,518
164 171 184 186 177 207 243 269 244 241 258 262 1,006
68 79 80 87 83 102 105 110 120 133 125 134 512
– – – 29 – – – 24 – – – – –
69 63 60 69 66 76 71 76 69 82 81 86 318
68 63 60 69 66 76 71 76 71 78 77 86 313
-0.7 16 20 18 18 26 34 34 48 54 48 48 198
9.2 9.4 9.3 5.7 8.2 9.2 13 8.5 13 13 11 10 48
-12 3.6 13 6.4 9.6 4.8 30 24 36 36 32 32 137
-4.0 2.3 4.5 5.7 2.6 1.7 8.8 6.6 9.7 9.0 8.3 11 38
-8.0 1.3 8.4 0.8 7.0 3.2 21 17 27 27 24 22 100
2.2 18 28 21 27 26 51 45 63 62 56 56 236

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?